Patent fight

Kyle Bass, a US hedge fund manager, is taking legal action against the US pharmaceutical industry. He plans on challenging drug patents of 15 companies that have a combined market cap of $450 billion. The founder of Hayman Capital claims that companies expand their patents by just changing the dosage or packaging. Part of an investment strategy, the legal challenge is likely to result in a fall of medicine prices in the US.